Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension

The American Review of Respiratory Disease
M N GillespieJ W Olson

Abstract

Multiple lines of evidence suggest that the polyamines, a family of low-molecular-weight organic cations with documented regulatory note in cell growth and differentiation, are involved with hyperplastic and hypertrophic responses of lung cells underlying hypertensive pulmonary vascular disease. Little is known, however, of the factor(s) initiating polyamine synthesis in pulmonary hypertension. This study tested the key aspects of the hypothesis that augmented polyamine synthesis, and attendent vascular structural alterations in monocrotaline (MCT)-treated rats can be ascribed to elaboration of an epidermal growth factor (EGF)-like mitogen. In lungs of rats treated 4 days previously with 60 mg/kg, EGF-like immunoreactivity was detected diffusely throughout perivascular regions. Intravenous administration of human recombinant EGF (125 pg/h) to rats for 1 wk was associated with medial thickening in pulmonary arteries between 100 and 200 microns in diameter, significant increases in lung polyamine contents, and a moderate elevation in mean pulmonary arterial pressure. These observations indicate that EGF can be detected in the lungs of MCT-treated rats and that exogenous EGF mimics some of the action of MCT on the rat lung. It is ...Continue Reading

References

Sep 1, 1986·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·E C SalidoD A Fisher
Jan 1, 1985·Journal of Leukocyte Biology·E J Kovacs, J Kelley
Jul 1, 1983·The Journal of Clinical Investigation·Y Oka, D N Orth
Nov 1, 1982·The American Journal of Physiology·A E Pegg, P P McCann

❮ Previous
Next ❯

Citations

May 31, 1994·Toxicology·P M BummerM N Gillespie
Dec 26, 2001·Pharmacology & Therapeutics·T K Jeffery, J C Wanstall
Feb 18, 2010·Cardiology in Review·Rajamma Mathew
Jan 1, 1997·Annual Review of Physiology·K R Stenmark, R P Mecham
Jan 1, 1992·Critical Reviews in Toxicology·D W WilsonD Morin
Jan 29, 2014·Circulation·Friederike Christine WeiselGrazyna Kwapiszewska
Aug 17, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·J A FlorianS W Watts
Apr 22, 2016·American Journal of Physiology. Cell Physiology·Prasanna AbeyrathnaYunchao Su
Sep 29, 2000·American Journal of Physiology. Heart and Circulatory Physiology·K M ItoK Ito
Oct 20, 1998·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·A E Schultze, R A Roth
Jan 15, 2003·Progress in Cardiovascular Diseases·T K Jeffery, N W Morrell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.